Pirmdiena, 23. marts   Šī ir funkcionējoša termini.lza.lv versija. Apmeklējiet arī Latvijas Nacionālo terminoloģijas portālu.
  Sākumlapa
  Terminu datubāze
  Struktūra un principi
  Apakškomisijas
  Sēdes
  Lēmumi
  Protokoli
  Vēstules
  Publikācijas
  Konsultācijas
  Vārdnīcas
  EuroTermBank
  Par portālu
  Kontakti
  Resursi internetā
  «Terminoloģijas Jaunumi»
  Atbalstītāji
  Notikumi
LZA TK termini atrodami Akadēmiskajā terminu datubāzē AkadTerm

Vēlaties portāla jaunumus
saņemt pa e-pastu?
Norādiet savu adresi:

Pakalpojumu nodrošina FeedBlitz

AkadTerm – plašākā latviešu terminu datubāze
 Palīdzība
Izmantojiet zvaigznīti * vārda daļu meklēšanai (piemēram, dator* vai *pratība)
Nozares:
Kolekcijas:
Jūs meklējāt R
Atrasti 103 termini

▪ {(S)-[(R)-2-methyl-1-propionyloxypropoxy](4-phenylbutyl)phosphinoyl}acetic acid
▪ (2S)-N-[(R)-1-(1,3-benzodioxol-5-yl)butyl]-3,3-diethyl-2-{4-[(4-methylpiperazin-1-yl)carbonyl]phenoxy}-4-oxoazetidine-1-carboxamide
▪ 3-acetoxymethyl-7-[(R)-2-formyloxy-2-phenylacetamido]-3-cephem-4-carboxylic acid
▪ (3S,4R)-3-[(R)-1-(tert-butyldimethylsilyloxy)ethyl]-4-[(1R,3S)-3-methoxy-2-oxocyclohexyl]azetidin-2-one
▪ (3S,4R)-4-acetoxy-3-[(R)-1-(tert-butyldimethylsilyloxy)ethyl]azetidin-2-one
▪ (3S,4S)-3-hexyl-4-[(R)-2-(hydroxytridecyl)]oxetan-2-one
▪ 4-nitrobenzyl (4R,5R,6S)-3-(diphenoxyphosphoryloxy)-6-[(R)-1-hydroxyethyl]-4-methyl-7-oxo-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylate
▪ 4-tert-butylbenzyl 2-{(2R,3S)-3-[(R)-1-(tert-butyldimethylsilyloxy)ethyl]-2-[(1R,3S)-3-methoxy-2-oxocyclohexyl]-4-oxoazetidin-1-yl}-2-oxoacetate
▪ 5-bromo-3-[(R)-1-methylpyrrolidin-2-ylmethyl]indole
▪ 5-[(R)-(2-aminopropyl)]-2-methoxybenzenesulfonamide
▪ 7-[(R)-amino(phenyl)acetamido]-3-methyl-3-cephem-4-carboxylic acid
▪ A/R
▪ A&R
▪ aeronautical mobile (R) service
▪ aeronautical safety type (AM(R)S, AMS(R)S, ARNS) spectrum
▪ AMS(R)S
▪ arms lateral L (R)
▪ bis[(isopropyloxycarbonyloxy)methyl [(R)-2-(6-amino-9H-purin-9-yl)-1-methylethoxy]methylphosphonate
▪ B.R. No.
▪ Common European Data Space for R&I
▪ ethyl (R)-2-hydroxy-4-phenylbutyrate
▪ EU R&I partnership
▪ F.O.R. price
▪ F.R. No.
▪ Global AMR R&D Hub
▪ I+R Directive
▪ intramural expenditure on R&D
▪ intramural R&D expenditure
▪ kick R leg forward
▪ KR&R
▪ low R&I performing country
▪ methyl (R)-3-hydroxybutyrate
▪ M.O.R.
▪ N-[(R)-2-({(R)-2-[(2-adamantyloxycarbonyl)amino]-3-(1H-indol-3-yl)-2-methyl-1-oxopropyl}amino)-1-phenylethyl]succinamic acid
▪ N-[(R)-9-methyl-4-oxo-1-phenyl-3,4,6,7-tetrahydro[1,4]diazepino[6,7,1-hi]indol-3-yl]isonicotinamide
▪ O/R address
▪ O/R name
▪ Ocean R&I Strategy
▪ outer cross-seat on the L/R thigh
▪ P&R policy
▪ P+R
▪ p-nitrobenzyl (2R,5R,6S)-6-[(R)-1-hydroxyethyl]-3,7-dioxo-1-azabicyclo[3.2.0]heptane-2-carboxylate
▪ ponceau 6 R
▪ potassium (R)-2-(4-hydroxyphenyl)-N-(3-methoxy-1-methyl-3-oxoprop-1-enyl)glycinate
▪ potassium (R)-N-(3-ethoxy-1-methyl-3-oxoprop-1-enyl)-2-phenylglycine
▪ potassium (R)-N-(3-methoxy-1-methyl-3-oxoprop-1-enyl)-2-phenylglycinate
▪ R
▪ R/T
▪ R/V
▪ R&B
▪ R&D
▪ R&D&I
▪ R&D&I Framework
▪ R&I
▪ R&R Guidelines
▪ R&D
▪ R& D activity
▪ R& D aid
▪ R & D costs
▪ R & D defence
▪ R&D expenditure
▪ R & D general public services
▪ R&D-intensive industry
▪ R & D public order and safety
▪ R & D Services
▪ R&TD Framework Programme
▪ (R)-1,2,3,4-tetrahydropapaverine hydrochloride
▪ (R)-2-(2,4-difluorophenyl)-3-(1H-1,2,4-triazol-1-yl)propane-1,2-diol
▪ (R)-2-(3-benzoylphenyl)propionic acid
▪ (R)-2-(6-amino-9H-purin-9-yl)-1-methylethanol
▪ (R)-[2-(6-amino-9H-purin-9-yl)-1-methylethoxy]methylphosphonic acid
▪ (R)-2-amino-2-ethylhexan-1-ol
▪ (R)-3-chloropropane-1,2-diol
▪ (R)-6,7-dimethoxy-2-methyl-1-(3,4,5-trimethoxybenzyl)-1,2,3,4-tetrahydroisoquinoline
▪ (R)-alpha-(chlorocarbonyl)benzyl formate
▪ (R)-alpha-cyano-3-phenoxybenzyl(Z)-(lS,3S)-3-(2-chloro-3, 3, 3-trifluoropropenyl)-2,2-dimethylcyclopropane-carboxylate
▪ R arm
▪ R arm circle
▪ R arm circle inward (outward)
▪ R arm obliquely upward
▪ R arm to the side
▪ required subdivision index R
▪ Resistive (R), Capacitive (C) and Inductive (L) Circuits
▪ R.H.
▪ R (L) knee hang
▪ R.M.S.V.
▪ R.M.S. value
▪ (R)-N-(1-{3-[1-benzoyl-3-(3,4-dichlorophenyl)-3-piperidyl]propyl}-4-phenyl-4-piperidyl)-N-methylacetamide hydrochloride
▪ R phrase
▪ (R)-p-mentha-1,8-diene
▪ R point
▪ (R)-propylene carbonate
▪ R.Q.
▪ S/R differences
▪ S.M.A.R.T. goal methodology
▪ sodium (R)-1-[(1-{3-[2-(7-chloro-2-quinolyl)vinyl]phenyl}-3-[2-(1-hydroxy-1-methylethyl)phenyl]propyl)thiomethyl]cyclopropylacetate
▪ sodium (R)-2-(4-hydroxyphenyl)-N-(3-methoxy-1-methyl-3-oxoprop-1-enyl)glycinate
▪ sodium (R)-N-(3-methoxy-1-methyl-3-oxoprop-1-enyl)-2-phenylglycinate
▪ speculative R&D
▪ squat support on the R/L leg
▪ S.R.F.
▪ T.C.R. No.
▪ total intramural R&D expenditure
  1. EN low R&I performing country; widening country
    LV paplašināšanas valsts; valstis ar zemu sniegumu pētniecībā un inovācijā
    DE Ausweitungsland; Land mit geringer FuI-Leistung
    FR pays peu performants en matière de R&I; pays bénéficiant de l’élargissement de la participation au programme; pays de l’élargissement
    Sk. IATE šķirkli.
    Download IATE © European Union, 2026
© 2005–2026 Latvijas Zinātņu akadēmija